Trump gives US-China trade talks another four weeks

Published 05-APR-2019 10:25 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

President Donald Trump on Thursday said the United States and China were a month from a potentially "epic" trade agreement writes Jerome Cartillier and Douglas Gillison.

But, nine months into the two countries' trade war, the announcement was anticlimactic, as the White House had earlier stoked anticipation that Trump could announce a date for a summit to clinch a final deal with his Chinese counterpart Xi Jinping.

Global markets had also rallied in recent days, roused by the hope that an end to the skirmish between the world's two top economies was at last at hand.

"We will probably know over the next four weeks. It may take two weeks after that," Trump told reporters following a meeting with Beijing's trade envoy Liu He.

"It's looking very good."

The talks are due to continue for a third day on Friday. Trump had said as far back as February that a summit could occur within a month.

Despite Trump's rosy gloss on the talks on Thursday, US Trade Representative Robert Lighthizer told reporters that major issues were left to be resolved.

Both US and Chinese officials have projected cautious optimism for months, but the last mile is proving to be the hardest, with the two sides reportedly tussling over whether and when Washington should remove the punishing tariffs it imposed last year on Chinese goods.

Trump in early 2018 launched a trade war with China, seeking to slash that country's soaring trade surplus with the United States, end alleged unfair trade practices such as the theft of American technology and China's massive state intervention in markets.

Washington and Beijing since last year have imposed tariffs on more than $360 billion in two-way trade, biting into their manufacturing sectors as the world economy slows.

China has floated offers to make sizable purchases of US commodities and taken steps to show it will protect foreign intellectual property.

But Democrats have warned of the temptation to accept a superficial deal that does not extract profound changes to the Chinese industrial policies American officials have long denounced.

Trump reiterated Thursday however that, "if it's not a great deal, we're not doing it."

- A tariff compromise? -

A final sticking point appears to be when and how Washington will agree to lift the steep tariffs it has placed on more than $250 billion in Chinese imports.

Last month, Trump said the tariffs would stay in place for "a substantial period," although whether this would apply to both tranches of goods subjected to the new duties was unclear.

US officials demand that any agreement have teeth and Lighthizer, the US trade representative, has said tariffs offer crucial leverage should Beijing backslide on its commitments.

Gary Clyde Hufbauer, a former US trade official and senior fellow at the Peterson Institute for International Economics, said lifting the tariffs too early could encourage criticism from Democrats that he had gone soft in the negotiations.

"The White House response to this drama is to keep the tariffs and only to slowly lower the rate as the Chinese fulfill their commitments," Hufbauer told AFP.

"The Chinese strategy is to have them get rid of it," he said. "My guess is that something in between will be in the compromise."

Analysts say any agreement is likely to include banner announcements that China has agreed to increase purchases of American commodities like soybeans and fuel.

This could perversely serve to give Chinese state enterprises a greater market role while making US exporters more reliant on the Chinese government's purchasing decisions -- both possibly contrary to US objectives and interests.

William Reinsch, a trade expert at the Center for Strategic and International Studies and former Commerce Department official for exports, pointed to Beijing's boycott of US soybean exports last year.

American producers could struggle to fill major new orders announced by Beijing, he said.

"The only way they can buy every bean is if we stop selling to everybody else and that puts us in an enormous position of vulnerability," he said.

© Agence France-Presse

tags

CHINA


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X